Use of a novel docosahexaenoic acid (DHA) formulation versus control in a neonatal porcine model of short bowel syndrome leads to greater intestinal absorption and higher systemic levels of DHA

Infants with short bowel syndrome (SBS) are at high risk for malabsorption, malnutrition, and failure to thrive. The objective of this study was to evaluate in a porcine model of SBS, the systemic absorption of a novel enteral Docosahexaenoic acid (DHA) formulation that forms micelles independent of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nutr Res
Päätekijät: Martin, Camilia R., Stoll, Barbara, Cluette-Brown, Joanne, Akinkuotu, Adesola C., Olutoye, Oluyinka O., Gura, Kathleen M., Singh, Pratibha, Zaman, Munir M., Perillo, Michael C., Puder, Mark, Freedman, Steven D., Burrin, Doug
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5392410/
https://ncbi.nlm.nih.gov/pubmed/28385289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nutres.2017.02.004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia